Anti-MAG associated cerebellar ataxia and response to rituximab.
Panagiotis ZisDasappaiah Ganesh RaoNigel HoggardPtolemaios Georgios SarrigiannisMarios HadjivassiliouPublished in: Journal of neurology (2017)
Anti-MAG antibodies might be involved in the pathogenesis of idiopathic sporadic ataxias, even in the absence of peripheral neuropathy. Rituximab seems to be a promising therapeutic intervention for those cases.